Xiao-Ying Meng
Overview
Explore the profile of Xiao-Ying Meng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
512
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wilson A, Kimura E, Harada R, Nair N, Narasimhan B, Meng X, et al.
Circulation
. 2007 Aug;
116(12):1396-403.
PMID: 17724262
Background: Peripheral arterial disease (PAD) is common but commonly unrecognized. Improved recognition of PAD is needed. We used high-throughput proteomic profiling to find PAD-associated biomarkers. Methods And Results: Plasma was...
2.
Aivado M, Spentzos D, Germing U, Alterovitz G, Meng X, Grall F, et al.
Proc Natl Acad Sci U S A
. 2007 Jan;
104(4):1307-12.
PMID: 17220270
Myelodysplastic syndromes (MDS) are among the most frequent hematologic malignancies. Patients have a short survival and often progress to acute myeloid leukemia. The diagnosis of MDS can be difficult; there...
3.
Moore L, Fung E, McGuire M, Rabkin C, Molinaro A, Wang Z, et al.
Cancer Epidemiol Biomarkers Prev
. 2006 Sep;
15(9):1641-6.
PMID: 16985025
Background: Although overall 5-year survival rates for ovarian cancer are poor (10-30%), stage I/IIa patients have a 95% 5-year survival. New biomarkers that improve the diagnostic performance of existing tumor...
4.
Li J, Orlandi R, White C, Rosenzweig J, Zhao J, Seregni E, et al.
Clin Chem
. 2005 Oct;
51(12):2229-35.
PMID: 16223889
Background: We previously selected a panel of 3 breast cancer biomarkers (BC1, BC2, and BC3) from serum samples collected at a single hospital based on their collective contribution to the...
5.
Fung E, Yip T, Lomas L, Wang Z, Yip C, Meng X, et al.
Int J Cancer
. 2005 Feb;
115(5):783-9.
PMID: 15704152
Protein expression profiling has been increasingly used to discover and characterize biomarkers that can be used for diagnostic, prognostic or therapeutic purposes. Most proteomic studies published to date have identified...
6.
Wang Z, Yip C, Ying Y, Wang J, Meng X, Lomas L, et al.
Clin Chem
. 2004 Oct;
50(10):1939-42.
PMID: 15484332
No abstract available.
7.
Zhang Z, Bast Jr R, Yu Y, Li J, Sokoll L, Rai A, et al.
Cancer Res
. 2004 Aug;
64(16):5882-90.
PMID: 15313933
Early detection remains the most promising approach to improve long-term survival of patients with ovarian cancer. In a five-center case-control study, serum proteomic expressions were analyzed on 153 patients with...
8.
Gilbert K, Figueredo S, Meng X, Yip C, Fung E
Methods Mol Biol
. 2004 Mar;
264:259-69.
PMID: 15020796
Protein-expression profiling of serum is a common approach to the discovery of potential diagnostic and therapeutic markers of disease. Like any other proteome, the serum proteome is characterized by protein...